Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

Go back to Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
(NASDAQ: AUTL) Delayed: 1.92 +0.05 (2.67%)
Previous Close $1.87    52 Week High
Open $1.92    52 Week Low
Day High $1.95    P/E N/A 
Day Low $1.89    EPS
Volume 772,239